Jubilant Biosys, a contract research organization and drug discovery company, completed the merger with Jubilant Chemsys, an Indian pharmaceutical company. Financial terms were not disclosed. "We are delighted to make this merger happen and focus our investments for growth to expand both the chemistry as well as integrated drug discovery capabilities. It provides clarity to customers and enables us to better deliver on our '4D' promise of accelerating the discovery process through increased digitization of our operations and information flow," Marcel Velterop, Jubilant Biosys President.